COVIVIO (COV.PA) Stock Fundamental Analysis

EPA:COV • FR0000064578

55.9 EUR
-0.75 (-1.32%)
Last: Feb 18, 2026, 04:25 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to COV. COV was compared to 41 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • COV had positive earnings in the past year.
  • In the past year COV had a positive cash flow from operations.
  • Of the past 5 years COV 4 years were profitable.
  • COV had a positive operating cash flow in each of the past 5 years.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

  • With a Return On Assets value of 1.63%, COV perfoms like the industry average, outperforming 46.34% of the companies in the same industry.
  • COV has a Return On Equity (5.08%) which is in line with its industry peers.
  • With a Return On Invested Capital value of 3.21%, COV perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
  • COV had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 3.45%.
  • The last Return On Invested Capital (3.21%) for COV is above the 3 year average (2.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROIC 3.21%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 30.43%, COV is in line with its industry, outperforming 46.34% of the companies in the same industry.
  • In the last couple of years the Profit Margin of COV has declined.
  • COV's Operating Margin of 57.80% is on the low side compared to the rest of the industry. COV is outperformed by 63.41% of its industry peers.
  • COV's Operating Margin has been stable in the last couple of years.
  • COV has a Gross Margin of 74.42%. This is comparable to the rest of the industry: COV outperforms 56.10% of its industry peers.
  • In the last couple of years the Gross Margin of COV has remained more or less at the same level.
Industry RankSector Rank
OM 57.8%
PM (TTM) 30.43%
GM 74.42%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COV is destroying value.
  • The number of shares outstanding for COV has been increased compared to 1 year ago.
  • COV has more shares outstanding than it did 5 years ago.
  • COV has a better debt/assets ratio than last year.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • COV has an Altman-Z score of 0.54. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.54, COV is not doing good in the industry: 70.73% of the companies in the same industry are doing better.
  • COV has a debt to FCF ratio of 28.49. This is a negative value and a sign of low solvency as COV would need 28.49 years to pay back of all of its debts.
  • COV has a worse Debt to FCF ratio (28.49) than 70.73% of its industry peers.
  • A Debt/Equity ratio of 1.07 is on the high side and indicates that COV has dependencies on debt financing.
  • COV has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: COV underperforms 78.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.49
Altman-Z 0.54
ROIC/WACC0.55
WACC5.85%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
  • COV has a Current ratio of 0.76. This is in the better half of the industry: COV outperforms 68.29% of its industry peers.
  • A Quick Ratio of 0.69 indicates that COV may have some problems paying its short term obligations.
  • COV has a better Quick ratio (0.69) than 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.69
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • COV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.98%.
  • The Earnings Per Share has been decreasing by -3.39% on average over the past years.
  • COV shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.96%.
  • Measured over the past years, COV shows a small growth in Revenue. The Revenue has been growing by 1.17% on average per year.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.53% on average over the next years.
  • COV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.10% yearly.
EPS Next Y5.02%
EPS Next 2Y3.41%
EPS Next 3Y3.53%
EPS Next 5YN/A
Revenue Next Year1.77%
Revenue Next 2Y3.17%
Revenue Next 3Y4.1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • COV is valuated correctly with a Price/Earnings ratio of 12.13.
  • Based on the Price/Earnings ratio, COV is valued a bit cheaper than the industry average as 65.85% of the companies are valued more expensively.
  • COV is valuated cheaply when we compare the Price/Earnings ratio to 27.16, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 11.69, the valuation of COV can be described as reasonable.
  • COV's Price/Forward Earnings ratio is in line with the industry average.
  • COV is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.13
Fwd PE 11.69
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, COV is valued a bit cheaper than the industry average as 60.98% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, COV is valued a bit more expensive than the industry average as 65.85% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 15.89
EV/EBITDA 17.11
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.42
PEG (5Y)N/A
EPS Next 2Y3.41%
EPS Next 3Y3.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • COV has a Yearly Dividend Yield of 6.43%, which is a nice return.
  • Compared to an average industry Dividend Yield of 5.33, COV pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, COV pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.43%

5.2 History

  • The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

  • 92.86% of the earnings are spent on dividend by COV. This is not a sustainable payout ratio.
DP92.86%
EPS Next 2Y3.41%
EPS Next 3Y3.53%
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVIVIO

EPA:COV (2/18/2026, 4:25:51 PM)

55.9

-0.75 (-1.32%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A
Earnings (Next)02-18
Inst Owners42.11%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.24B
Revenue(TTM)1.37B
Net Income(TTM)417.40M
Analysts75
Price Target63.81 (14.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.43%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.86%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.39%
PT rev (3m)-0.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.88%
Valuation
Industry RankSector Rank
PE 12.13
Fwd PE 11.69
P/S 4.55
P/FCF 15.89
P/OCF 6.22
P/B 0.76
P/tB 0.79
EV/EBITDA 17.11
EPS(TTM)4.61
EY8.25%
EPS(NY)4.78
Fwd EY8.55%
FCF(TTM)3.52
FCFY6.29%
OCF(TTM)8.99
OCFY16.08%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)2.42
PEG (5Y)N/A
Graham Number87.41
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROCE 3.59%
ROIC 3.21%
ROICexc 3.42%
ROICexgc 3.48%
OM 57.8%
PM (TTM) 30.43%
GM 74.42%
FCFM 28.62%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexgc growth 3Y12.16%
ROICexgc growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.49
Debt/EBITDA 9.39
Cap/Depr 415.79%
Cap/Sales 44.53%
Interest Coverage 250
Cash Conversion 106.78%
Profit Quality 94.06%
Current Ratio 0.76
Quick Ratio 0.69
Altman-Z 0.54
F-Score7
WACC5.85%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y5.02%
EPS Next 2Y3.41%
EPS Next 3Y3.53%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year1.77%
Revenue Next 2Y3.17%
Revenue Next 3Y4.1%
Revenue Next 5YN/A
EBIT growth 1Y-0.75%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year12.83%
EBIT Next 3Y8.07%
EBIT Next 5Y7.52%
FCF growth 1Y41.8%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.51%
OCF growth 3Y12.5%
OCF growth 5Y4.86%

COVIVIO / COV.PA FAQ

Can you provide the ChartMill fundamental rating for COVIVIO?

ChartMill assigns a fundamental rating of 3 / 10 to COV.PA.


What is the valuation status for COV stock?

ChartMill assigns a valuation rating of 4 / 10 to COVIVIO (COV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for COVIVIO?

COVIVIO (COV.PA) has a profitability rating of 4 / 10.


What is the financial health of COVIVIO (COV.PA) stock?

The financial health rating of COVIVIO (COV.PA) is 1 / 10.


How sustainable is the dividend of COVIVIO (COV.PA) stock?

The dividend rating of COVIVIO (COV.PA) is 4 / 10 and the dividend payout ratio is 92.86%.